CIK 0001582313
- Large accelerated filer
Xenon Pharmaceuticals Inc.
Sign in to watch- Ticker
- XENE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- EIN
- 980661854
- Phone
- +1 604-484-3300
- Business address
- 200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
- Open-market buys, last 90 days
- $1,681,140
- in 2 filings
- Open-market sales, last 90 days
- $425,829
- in 1 filing, $426K under 10b5-1 plans
Net +$1,255,311. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-08-18 | ROBIN SHERRINGTON SVP Bus. & Corp. Development | Exercise or conversion | +1,028 | $4.81 | $5K | 3,085 |
| 2015-08-18 | ROBIN SHERRINGTON SVP Bus. & Corp. Development | Shares withheld for taxes | −434 | $11.00 | $5K | 2,651 |
| 2015-08-18 | ROBIN SHERRINGTON SVP Bus. & Corp. Development | Exercise or conversion | +2,057 | $4.98 | $10K | 4,708 |
| 2015-08-18 | ROBIN SHERRINGTON SVP Bus. & Corp. Development | Shares withheld for taxes | −868 | $11.00 | $10K | 3,840 |
| 2015-08-18 | ROBIN SHERRINGTON SVP Bus. & Corp. Development | Exercise or conversion · Stock Option (Right to Buy) | −1,028 | |||
| 2015-08-18 | ROBIN SHERRINGTON SVP Bus. & Corp. Development | Exercise or conversion · Stock Option (Right to Buy) | −2,057 | |||
| 2015-08-18 | PIMSTONE SIMON N. President & CEO | Exercise or conversion | +5,144 | $4.81 | $25K | 197,451 |
| 2015-08-18 | PIMSTONE SIMON N. President & CEO | Shares withheld for taxes | −2,170 | $11.00 | $24K | 195,281 |
| 2015-08-18 | PIMSTONE SIMON N. President & CEO | Exercise or conversion | +15,432 | $4.98 | $77K | 210,713 |
| 2015-08-18 | PIMSTONE SIMON N. President & CEO | Shares withheld for taxes | −6,508 | $11.00 | $72K | 204,205 |
| 2015-08-18 | PIMSTONE SIMON N. President & CEO | Exercise or conversion · Stock Option (Right to Buy) | −5,144 | 0 | ||
| 2015-08-18 | PIMSTONE SIMON N. President & CEO | Exercise or conversion · Stock Option (Right to Buy) | −15,432 | 0 | ||
| 2015-08-18 | HOLLER FRANK A Director | Exercise or conversion | +2,057 | $4.98 | $10K | 175,675 |
| 2015-08-18 | HOLLER FRANK A Director | Shares withheld for taxes | −868 | $11.00 | $10K | 174,807 |
| 2015-08-18 | HOLLER FRANK A Director | Exercise or conversion · Stock Option (Right to Buy) | −2,057 | 0 | ||
| 2015-08-18 | GOLDBERG Y. PAUL VP of Clinical Development | Exercise or conversion | +1,028 | $4.81 | $5K | 5,348 |
| 2015-08-18 | GOLDBERG Y. PAUL VP of Clinical Development | Shares withheld for taxes | −434 | $11.00 | $5K | 4,914 |
| 2015-08-18 | GOLDBERG Y. PAUL VP of Clinical Development | Exercise or conversion | +2,057 | $4.98 | $10K | 6,971 |
| 2015-08-18 | GOLDBERG Y. PAUL VP of Clinical Development | Shares withheld for taxes | −868 | $11.00 | $10K | 6,103 |
| 2015-08-18 | GOLDBERG Y. PAUL VP of Clinical Development | Exercise or conversion · Stock Option (Right to Buy) | −1,028 | 0 |
Page 38 of 42 · 836 trades